Reversal of pathological pain through specific spinal GABAA receptor subtypes
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
Inflammatory diseases and neuropathic insults are frequently accompanied by severe and debilitating pain, which can become chronic and often unresponsive to conventional analgesic treatment. A loss of synaptic inhibition in the spinal dorsal horn is considered to contribute significantly to this pain pathology. Facilitation of spinal gamma-aminobutyric acid (GABA)ergic neurotransmission through modulation of GABA(A) receptors should be able to compensate for this loss. With the use of GABA(A)-receptor point-mutated knock-in mice in which specific GABA(A) receptor subtypes have been selectively rendered insensitive to benzodiazepine-site ligands, we show here that pronounced analgesia can be achieved by specifically targeting spinal GABA(A) receptors containing the alpha2 and/or alpha3 subunits. We show that their selective activation by the non-sedative ('alpha1-sparing') benzodiazepine-site ligand L-838,417 (ref. 13) is highly effective against inflammatory and neuropathic pain yet devoid of unwanted sedation, motor impairment and tolerance development. L-838,417 not only diminished the nociceptive input to the brain but also reduced the activity of brain areas related to the associative-emotional components of pain, as shown by functional magnetic resonance imaging in rats. These results provide a rational basis for the development of subtype-selective GABAergic drugs for the treatment of chronic pain, which is often refractory to classical analgesics.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, in contrast to morphine, no analgesic tolerance occurred in rats after a 9-day treatment with the α 2/3 subtype GABAA receptor positive allosteric modulator L838,417 using a model of neuropathic pain [157].”
From Mechanisms Underlying Tolerance after Long-Term Benzodiazepine Use: A Future for Subtype-Selective Receptor Modulators? (2012) · cites this paper as [157]
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
The rat brain in stereotaxic coordinates
Palkovits, M. (1983) · Neuropeptides · doi:10.1016/0143-4179(83)90049-5 · Cited by 28,831
Melzack, R., & Wall, P. D. (1965) · Science · doi:10.1126/science.150.3699.971 · Cited by 11,090
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man
Bennett, G. J., & Xie, Y.-K. (1988) · Pain · doi:10.1016/0304-3959(88)90209-6 · Cited by 5,376
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
Hargreaves, K., Dubner, R., Brown, F., Flores, C., & Joris, J. (1988) · Pain · doi:10.1016/0304-3959(88)90026-7 · Cited by 5,135
Neuronal plasticity: Increasing the gain in pain
Woolf, C. J., & Salter, M. W. (2000) · Science · doi:10.1126/science.288.5472.1765 · Cited by 3,781
Dubuisson, D., & Dennis, S. G. (1977) · Pain · doi:10.1016/0304-3959(77)90130-0 · Cited by 2,524
RARE imaging: A fast imaging method for clinical MR
Hennig, J., Nauerth, A., & Friedburg, H. (1986) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910030602 · Cited by 2,081
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Cited by
Cellular and Molecular Mechanisms of Pain
Basbaum, A. I., Bautista, D. M., Scherrer, G., & Julius, D. (2009) · Cell · doi:10.1016/j.cell.2009.09.028 · Cited by 4,344
Neuropathic Pain: A Maladaptive Response of the Nervous System to Damage
Costigan, M., Scholz, J., & Woolf, C. J. (2009) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135531 · Cited by 2,025
The effect of pain on cognitive function: A review of clinical and preclinical research
Moriarty, O., McGuire, B. E., & Finn, D. P. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.01.002 · Cited by 1,122
“…subtypes of GABAA receptors (containing α2 and/or α3 subunits) reduced inflammatory and nociceptive pain without causing adverse sedative effects (Knabl et al., 2008; Mohler, 2009), and selective inverse agonists of the α5 subunit enhance spatial learning in animal models (Maubach, 2003;…”
BackgroundModels and Mechanisms of Hyperalgesia and Allodynia
Sandkühler, J. (2009) · Physiological Reviews · doi:10.1152/physrev.00025.2008 · Cited by 1,148
“Specifically targeting spinal GABAA receptors containing the 2- and/or 3-subunits reveals antinociception with minor motor effects (250).”
BackgroundThe GABAergic deficit hypothesis of major depressive disorder
Luscher, B., Shen, Q., & Sahir, N. (2011) · Molecular Psychiatry · doi:10.1038/mp.2010.120 · Cited by 934
Deconstructing the Neuropathic Pain Phenotype to Reveal Neural Mechanisms
von Hehn, C. A., Baron, R., & Woolf, C. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.008 · Cited by 800
Central mechanisms of pathological pain
Kuner, R. (2010) · Nature Medicine · doi:10.1038/nm.2231 · Cited by 790
“Modulating the activation of GABA A receptors with subunit-specific agonists may constitute a promising approach for inhibiting pathological pain without eliciting the numerous typical side effects of GABA A -modifying drug”
BackgroundBeyond classical benzodiazepines: novel therapeutic potential of GABAA receptor subtypes
Rudolph, U., & Knoflach, F. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3502 · Cited by 733
“When diazepam is administered intrathecally in α2(H101R) and α3(H126R) mice, its antihyperalgesic action is significantly reduced in models of inflammatory pain and of neuropathic pain, demonstrating that spinal α2- and α3-containing GABA A receptors are mediating the antihyperalgesic actions of intrathecal diazepa”
BackgroundSelf-citationThe GABA system in anxiety and depression and its therapeutic potential
Möhler, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.08.040 · Cited by 590
Self-citationNeuroinflammation and comorbidity of pain and depression
Walker, A. K., Kavelaars, A., Heijnen, C. J., & Dantzer, R. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008144 · Cited by 460
“Similarly, Knabl et al. (2008) investigated GABAA point-mutated knockin mice, in which GABAA receptor subtypes could be selectively desensitized to benzodiazepine-site ligands.”
BackgroundMorphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl− homeostasis
Ferrini, F., Trang, T., Mattioli, T.-A. M., Laffray, S., Del'Guidice, T., Lorenzo, L.-E., Castonguay, A., Doyon, N., Zhang, W., Godin, A. G., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3295 · Cited by 437
Chapman, C. R., & Vierck, C. J. (2017) · The Journal of Pain · doi:10.1016/j.jpain.2016.11.004 · Cited by 423
Fast Synaptic Inhibition in Spinal Sensory Processing and Pain Control
Zeilhofer, H. U., Wildner, H., & Yévenes, G. E. (2012) · Physiological Reviews · doi:10.1152/physrev.00043.2010 · Cited by 371
“At first glance, the idea of GABA acting as an excitatory transmitter in neuropathic pain states seems to be at odds with the observation that facilitation of GABAA receptors by benzodiazepines, under these conditions, produces antihyperalgesic effects (196, 200).”
InfluentialSelf-citationBreaking barriers to novel analgesic drug development
Yekkirala, A. S., Roberson, D. P., Bean, B. P., & Woolf, C. J. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.87 · Cited by 364
P2X4R+ microglia drive neuropathic pain
Beggs, S., Trang, T., & Salter, M. W. (2012) · Nature Neuroscience · doi:10.1038/nn.3155 · Cited by 360
Blockade of TNF-α rapidly inhibits pain responses in the central nervous system
Hess, A., Axmann, R., Rech, J., Finzel, S., Heindl, C., Kreitz, S., Sergeeva, M., Saake, M., Garcia, M., Kollias, G., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011774108 · Cited by 356
“3) and our own softwareMagnAn (25), as previously described (28).”
BackgroundSelf-citationFoster, E., Wildner, H., Tudeau, L., Haueter, S., Ralvenius, W. T., Jegen, M., Johannssen, H., Hösli, L., Haenraets, K., Ghanem, A., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.028 · Cited by 356
“Silencing and ablation of these neurons induces local hyperalgesia and spontaneous discomfort, whereas their activation alleviates pain and itch.”
BackgroundResultSelf-citationNeely, G. G., Hess, A., Costigan, M., Keene, A. C., Goulas, S., Langeslag, M., Griffin, R. S., Belfer, I., Dai, F., Smith, S. B., et al. (2010) · Cell · doi:10.1016/j.cell.2010.09.047 · Cited by 307
Self-citationAdvances in understanding nociception and neuropathic pain
St. John Smith, E. (2018) · Journal of Neurology · doi:10.1007/s00415-017-8641-6 · Cited by 282
“Indeed, in rodents, positive modulation of α2 and/or α3 subunit containing GABAA receptors reverses neuropathic pain [87].”
BackgroundEpigenetic suppression of GAD65 expression mediates persistent pain
Zhang, Z., Cai, Y.-Q., Zou, F., Bie, B., & Pan, Z. Z. (2011) · Nature Medicine · doi:10.1038/nm.2442 · Cited by 281
Chloride regulation in the pain pathway
Price, T. J., Cervero, F., Gold, M. S., Hammond, D. L., & Prescott, S. A. (2009) · Brain Research Reviews · doi:10.1016/j.brainresrev.2008.12.015 · Cited by 264
Tests of unconditioned anxiety — Pitfalls and disappointments
Ennaceur, A. (2014) · Physiology & Behavior · doi:10.1016/j.physbeh.2014.05.032 · Cited by 259
“sleep [219], and contribute to the reinforcing effects of drugs of abuse [113,284], that α3-GABAA receptors mediate benzodiazepines-induced hyperphagia [285] and that both α2- and α3-containing GABAA receptors mediate the rewarding [322] and analgesic [107,182,214,215,287]”
BackgroundReactivation of Dormant Relay Pathways in Injured Spinal Cord by KCC2 Manipulations
Chen, B., Li, Y., Yu, B., Zhang, Z., Brommer, B., Williams, P. R., Liu, Y., Hegarty, S. V., Zhou, S., Zhu, J., et al. (2018) · Cell · doi:10.1016/j.cell.2018.06.005 · Cited by 253
“As a control, we examined c-Fos immunoreactivity in the spinal cord of staggered injured mice following chronic treatment with L838,417, a GABA agonist that has been shown to reduce neuropathic pain (Knabl et al., 2008).”
Chloride Regulation: A Dynamic Equilibrium Crucial for Synaptic Inhibition
Doyon, N., Vinay, L., Prescott, S. A., & De Koninck, Y. (2016) · Neuron · doi:10.1016/j.neuron.2016.02.030 · Cited by 252
GABA Neuron Alterations, Cortical Circuit Dysfunction and Cognitive Deficits in Schizophrenia
Gonzalez-Burgos, G., Fish, K. N., & Lewis, D. A. (2011) · Neural Plasticity · doi:10.1155/2011/723184 · Cited by 246
“Immunoreactivity for ankyrin-G, βIV spectrin, and gephyrin (a scaffolding protein that regulates the clustering of GABAARs containing α2 subunits at AIS) [202–204] also exhibit substantial changes during postnatal development [205].”
BackgroundRegulation of GABAA Receptor Subunit Expression by Pharmacological Agents
Uusi-Oukari, M., & Korpi, E. R. (2010) · Pharmacological Reviews · doi:10.1124/pr.109.002063 · Cited by 213
Bráz, J. M., Sharif-Naeini, R., Vogt, D., Kriegstein, A., Alvarez-Buylla, A., Rubenstein, J. L., & Basbaum, A. I. (2012) · Neuron · doi:10.1016/j.neuron.2012.02.033 · Cited by 215
“into Adult Spinal Cord and Reduce Injury-Induced”
BackgroundGABA and central neuropathic pain following spinal cord injury
Gwak, Y. S., & Hulsebosch, C. E. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.12.030 · Cited by 214
“The chloride gradient in the neural membrane is critically important to GABAA receptor mediated inhibitory function because the GABAA receptor is anion-permeable (Kaila, 1994).”
InfluentialSieghart, W., & Savić, M. M. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014449 · Cited by 210
“…(Löw et al., 2000). a2bg2 together with a3bg2 receptors seem to mediate some antinociceptive and muscle relaxant actions (Crestani et al., 2001;Knabl et al., 2008; Ralvenius et al., 2015), and a5bg2 receptors mediate the cognitive effects of benzodiazepine site ligands (Collinson et al.,…”
BackgroundMechanisms of neuropathic pain
Nickel, F. T., Seifert, F., Lanz, S., & Maihöfner, C. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.05.005 · Cited by 206
GABAA receptors and plasticity of inhibitory neurotransmission in the central nervous system
Fritschy, J., & Panzanelli, P. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12534 · Cited by 198
“More recent studies have shown a corresponding segregation of other effects of diazepam (and midazolam), including benzodiazepine addiction (Tan et al., 2010), tachypnea (Masneuf et al., 2012), and anti-hyperalgesia (Knabl et al., 2008), to specific GABAAR subtypes.”
BackgroundSelf-citationVinkers, C. H., & Olivier, B. (2012) · Advances in Pharmacological Sciences · doi:10.1155/2012/416864 · Cited by 195
Activation of cortical somatostatin interneurons prevents the development of neuropathic pain
Cichon, J., Blanck, T. J. J., Gan, W.-B., & Yang, G. (2017) · Nature Neuroscience · doi:10.1038/nn.4595 · Cited by 172
Chronic Pain States: Pharmacological Strategies to Restore Diminished Inhibitory Spinal Pain Control
Zeilhofer, H. U., Benke, D., & Yevenes, G. E. (2012) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010611-134636 · Cited by 162
Self-citationNerve Injury-Induced Neuropathic Pain Causes Disinhibition of the Anterior Cingulate Cortex
Blom, S. M., Pfister, J.-P., Santello, M., Senn, W., & Nevian, T. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3667-13.2014 · Cited by 160
“A loss in synaptic inhibition onto projecting neurons in the dorsal horn has been implicated in the development of inflammatory pain (Knabl et al. 2008).”
Rivat, C., Becker, C., Blugeot, A., Zeau, B., Mauborgne, A., Pohl, M., & Benoliel, J.-J. (2010) · Pain · doi:10.1016/j.pain.2010.05.031 · Cited by 159
“in reducing sensory hypersensitivity in defeated rats seems a little bit surprising since GABAA receptors through the activation of a2 and a3 subunits mediate the anti-nociceptive effects of benzodiazepine agonists [19,32].”
BackgroundAhrens, J., Demir, R., Leuwer, M., de la Roche, J., Krampfl, K., Foadi, N., Karst, M., & Haeseler, G. (2009) · Pharmacology · doi:10.1159/000201556 · Cited by 153
Fisher, J. L. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.06.004 · Cited by 156
“In addition, very recent studies suggest a potentially important role for α3-containing GABARs in spinal cord in the reduction of neuropathic and inflammatory pain (Knabl et al., 2008).”
BackgroundDoyon, N., Prescott, S. A., Castonguay, A., Godin, A. G., KRÖGER, H., & Koninck, Y. D. (2011) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002149 · Cited by 178
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
“benzodiazepine-site agonists, the efficacy of which is supposed to be dependent on KCC2-driven Cl(2) gradients, surprisingly show strong analgesic effects by ablating neuropathic pain symptoms (Knabl et al., 2008; Paul et al., 2014a), stressing that multiple parallel pathways are involved (Zeilhofer et al.”
BackgroundAcetazolamide and midazolam act synergistically to inhibit neuropathic pain
Asiedu, M. N., Ossipov, M. H., Kaila, K., & Price, T. J. (2009) · Pain · doi:10.1016/j.pain.2009.11.015 · Cited by 137
“On the other hand, after PNI, benzodiazepines generate anti-allodynia on the spinal level largely via a2- and a3-containing subunits suggesting that synaptic, or phasic, receptors are responsible for this effect [20].”
BackgroundInfluentialEngin, E., Liu, J., & Rudolph, U. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.08.006 · Cited by 129
Self-citationMiraucourt, L. S., Moisset, X., Dallel, R., & Voisin, D. L. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3923-08.2009 · Cited by 121
“This, combined with a selection of drugs that act on those mechanisms should make it possible to design optimal treatments for individual patients (Baron, 2006; Knabl et al., 2008).”
BackgroundAnimal Functional Magnetic Resonance Imaging: Trends and Path Toward Standardization
Mandino, F., Cerri, D. H., Garin, C. M., Straathof, M., van Tilborg, G. A. F., Chakravarty, M. M., Dhénain, M., Dijkhuizen, R. M., Gozzi, A., Heß, A., et al. (2020) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2019.00078 · Cited by 122
Ciguatoxins activate specific cold pain pathways to elicit burning pain from cooling
Vetter, I., Touška, F., Hess, A., Hinsbey, R., Sattler, S., Lampert, A., Sergejeva, M., Sharov, A., Collins, L. S., Eberhardt, M. J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.207 · Cited by 123
“Functional analysis was performed using Brain Voyager QX and our custom-designed software, MagNan (Knabl et al , 2008).”
Self-citationGABAergic analgesia: new insights from mutant mice and subtype-selective agonists
Zeilhofer, H. U., Möhler, H., & Lio, A. D. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.05.007 · Cited by 129
“[ 30 ]). (b) Distribution of benzodiazepine-sensitive GABAA receptor a subunits in the mouse spinal cord (courtesy of Jolly Paul and Jean-Marc Fritschy).”
BackgroundInfluentialSelf-citationPresynaptic α2-GABAAReceptors in Primary Afferent Depolarization and Spinal Pain Control
Witschi, R., Punnakkal, P., Paul, J., Walczak, J.-S., Cervero, F., Fritschy, J.-M., Kuner, R., Keist, R., Rudolph, U., & Zeilhofer, H. U. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6328-10.2011 · Cited by 114
“Conversely, hyperalgesia originating from inflammatory and neuropathic diseases can be reversed by local spinal or systemic administration of benzodiazepines (BDZs) such as diazepam (DZP) (Knabl et al., 2008) and midazolam (Kontinen and Dickenson, 2000), which enhance GABAA receptor activation.”
BackgroundMethodInfluentialSelf-citationSmith, K. S., & Rudolph, U. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.026 · Cited by 114
Self-citationThe Flavonoid Glycosides, Myricitrin, Gossypin and Naringin Exert Anxiolytic Action in Mice
Fernández, S. P., Nguyen, M., Yow, T. T., Chu, C., Johnston, G. A. R., Hanrahan, J. R., & Chebib, M. (2009) · Neurochemical Research · doi:10.1007/s11064-009-9969-9 · Cited by 122
“Third, inhibitory GABAergic and glycinergic neurons in the dorsal horn of the spinal cord control the transmission of nociceptive signals from the periphery to the CNS, and some benzodiazepines have been shown to exert weak antinociceptive actions [16].”
BackgroundSpinal presynaptic inhibition in pain control
Guo, D., & Hu, J. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.09.032 · Cited by 137
“Several reports have demonstrated GABA or GABAA receptor PAMs mediate robust analgesia, whereas others have found GABA or PAM exacerbate pain syndromes (Bianchi et al., 1993; Rode et al., 2005; Knabl et al., 2008; Munro et al., 2009, 2011; Mirza and Munro, 2010).”
InfluentialThe rise of a new GABA pharmacology
Möhler, H. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.10.020 · Cited by 119
“Importantly, a1 receptors whichmediate sedation, were not involved to the anti-hyperalgesic activity of diazepam (Knabl et al., 2008).”
BackgroundInfluentialSelf-citationKnabl, J., Zeilhofer, U. B., Crestani, F., Rudolph, U., & Zeilhofer, H. U. (2009) · Pain · doi:10.1016/j.pain.2008.10.015 · Cited by 111
“The contribution of the a3 subunit to diazepam-induced antinociception was more prominent in the present experiments than in the previous study [10].”
BackgroundMethodResultInfluentialSelf-citationGABA ergic signalling in the immune system
Barragán, A., Weidner, J. M., Jin, Z., Korpi, E. R., & Birnir, B. (2015) · Acta Physiologica · doi:10.1111/apha.12467 · Cited by 119
Smith, P. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.044 · Cited by 118
“has been shown to reverse signs of neuropathic pain in animal models (Knabl et al., 2008; Zeilhofer et al., 2012a,b; Besson et al., 2013; Paul et al., 2014).”
BackgroundHow to erase memory traces of pain and fear
Sandkühler, J., & Lee, J. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.03.004 · Cited by 108
Ralvenius, W. T., Benke, D., Acuña, M. A., Rudolph, U., & Zeilhofer, H. U. (2015) · Nature Communications · doi:10.1038/ncomms7803 · Cited by 105
Self-citationGuyon, A., Skrzydelski, D., Giry, I. D., Rovère, C., Conductier, G., Trocello, J., Daugé, V., Kitabgi, P., Rostène, W. H., Nahon, J., et al. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.05.048 · Cited by 123
Munro, G., Lopez-Garcia, J. A., Rivera‐Arconada, I., Erichsen, H. K., Nielsen, E. Ø., Larsen, J. S., Ahring, P. K., & Mirza, N. R. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.144568 · Cited by 107
“Recently, using a combination of molecular and pharmacological techniques, Knabl et al. (2008) reported that GABAA- 2/GABAA- 3 receptors are the principal contributors to spinal disinhibition occurring after injury.”
BackgroundResultInfluentialPre‐ and postsynaptic inhibitory control in the spinal cord dorsal horn
Bardoni, R., Takazawa, T., Tong, C., Choudhury, P., Scherrer, G., & MacDermott, A. B. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12056 · Cited by 101
Presynaptic GABAergic inhibition regulated by BDNF contributes to neuropathic pain induction
Chen, J. T.-C., Guo, D., Campanelli, D., Frattini, F., Mayer, F., Zhou, L., Kuner, R., Heppenstall, P. A., Knipper, M., & Hu, J. (2014) · Nature Communications · doi:10.1038/ncomms6331 · Cited by 100
Testing for ancient selection using cross-population allele frequency differentiation
Racimo, F. (2016) · Genetics · doi:10.1534/genetics.115.178095 · Cited by 96
“GABRA2 is significantly associated with risk of alcohol dependence in humans [Edenberg et al., 2004], perception of pain [Knabl et al., 2008] and asthma [Xiang et al., 2007].”
BackgroundA novel GABAAreceptor pharmacology: drugs interacting with the α+β‐interface
Sieghart, W., Ramerstorfer, J., Sarto‐Jackson, I., Varagić, Z., & Ernst, M. C. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01779.x · Cited by 111
“…the a2 subunit indicated that receptors containing a2 subunits seem to primarily mediate the anxiolytic, and partially also the muscle relaxant effects of diazepam (Low et al., 2000), and, in addition, seem to mediate the analgesic action of local diazepam in the spinal cord (Knabl et al., 2008).”
BackgroundHuang, M., Huang, T., Xiang, Y., Xie, Z., Chen, Y., Yan, R., Xu, J., & Cheng, L. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2008.06.031 · Cited by 107
Current status of GABA receptor subtypes in analgesia
Qian, X., Zhao, X., Yu, L., Yin, Y., Zhang, X., Wang, L., Li, J., Zhu, Q., & Luo, J. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115800 · Cited by 108
Cerne, R., LIPPA, A. S., Poe, M. M., Smith, J. L., Jin, X., Ping, X., Golani, L. K., Cook, J. M., & Witkin, J. M. (2021) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108035 · Cited by 95
Lio, A. D., Benke, D., Besson, M. J., Desmeules, J. A., Daali, Y., Wang, Z., Edwankar, R. V., Cook, J. M., & Zeilhofer, H. U. (2010) · Neuropharmacology · doi:10.1016/j.neuropharm.2010.11.026 · Cited by 98
Self-citationPaul, J., Zeilhofer, H. U., & Fritschy, J. (2012) · Journal of Comparative Neurology · doi:10.1002/cne.23129 · Cited by 87
“The present study confirms our previous observations (Knabl et al., 2008; Witschi et al., 2011) and provides proof-of-principle evidence that these GABAARs correspond, at least in part, to axoaxonic synapses, with a postsynaptic density containing the scaffolding protein gephyrin.”
BackgroundResultInfluentialSelf-citationMas-related G-protein–coupled receptors inhibit pathological pain in mice
Guan, Y., Liu, Q., Tang, Z., Raja, S. N., Anderson, D. J., & Dong, X. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1011221107 · Cited by 89
“was recorded for 60 min as previously described (23, 37).”
BackgroundMethodMirza, N. R., Larsen, J. S., Mathiasen, C., Jacobsen, T. A., Munro, G., Erichsen, H. K., Nielsen, A. N., Troelsen, K. B., NIELSEN, E. O., & Ahring, P. K. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.138859 · Cited by 89
“…the confidence that we have in attributing in vivo effects to NS11394 per se, this makes it an invaluable tool in posing questions regarding the relevant GABAA subtype selectivity profile necessary for efficacy in emerging therapeutic areas such as pain (see Munro et al., 2008; Knabl et al., 2008).”
BackgroundMuscle relaxants for pain management in rheumatoid arthritis
Richards, B. L., Whittle, S., & Buchbinder, R. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008922.pub2 · Cited by 90
Role of GABAA receptors in cognition
Möhler, H. (2009) · Biochemical Society Transactions · doi:10.1042/bst0371328 · Cited by 79
Self-citationFuccio, C., Luongo, C., Capodanno, P., Giordano, C., Scafuro, M. A., Siniscalco, D., Lettieri, B., Rossi, F., Maione, S., & Berrino, L. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.11.060 · Cited by 89
Munro, G., Ahring, P. K., & Mirza, N. R. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.06.004 · Cited by 84
Glycine receptors and glycine transporters: targets for novel analgesics?
Zeilhofer, H. U., Acuña, M. A., Gingras, J., & Yévenes, G. E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2622-x · Cited by 90
Self-citationMaramai, S., Benchekroun, M., Ward, S. E., & Atack, J. R. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01312 · Cited by 87
GABA Pharmacology: The Search for Analgesics
McCarson, K. E., & Enna, S. J. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1254-x · Cited by 82
Enhancing neuronal chloride extrusion rescues α2/α3 GABAA-mediated analgesia in neuropathic pain
Lorenzo, L.-É., Godin, A. G., Ferrini, F., Bachand, K., Plasencia-Fernández, I., Labrecque, S., Girard, A. A., Boudreau, D., Kianicka, I., Gagnon, M., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-14154-6 · Cited by 93
Bonin, R. P., Labrakakis, C., Eng, D. G., Whissell, P. D., Koninck, Y. D., & Orser, B. A. (2011) · Pain · doi:10.1016/j.pain.2011.02.011 · Cited by 85
“Compounds targeting benzodiazepinesensitive GABAAR subtypes show some promise [28,29]; however, the clinical utility of these compounds in the treatment of acute pain in humans has been limited [7,12,66].”
BackgroundGABAA Receptor α2/α3 Subtype-Selective Modulators as Potential Nonsedating Anxiolytics
Atack, J. R. (2009) · Current topics in behavioral neurosciences · doi:10.1007/7854_2009_30 · Cited by 86
Braz, J. M., Wang, X., Guan, Z., Rubenstein, J. L. R., & Basbaum, A. I. (2015) · Pain · doi:10.1097/j.pain.0000000000000152 · Cited by 72
“Consistent with this conclusion, we previously demonstrated that MGE transplants are not effective in the formalin test,(7) a model of postoperative/inflammatory pain that responds well to intrathecal administration of GABA agonists.(20,24,25,27,30,37) In conclusion, in this study, we provide further evidence for the…”
ResultFlupirtine, a re-discovered drug, revisited
Szelenyi, I. (2013) · Inflammation Research · doi:10.1007/s00011-013-0592-5 · Cited by 69
“There is evidence that intrathecally applied benzodiazepines, which enhance GABAA receptor-mediated synaptic inhibition, elicit profound antinociceptive/analgesic effects in both animals [39, 40] and humans [41].”
BackgroundChristian, E. P., Snyder, D. H., Song, W., Gurley, D. A., Smolka, J., Maier, D. L., Ding, M., Gharahdaghi, F., Liu, X. F., Chopra, M., et al. (2015) · Journal of Neurophysiology · doi:10.1152/jn.00539.2013 · Cited by 68
Aman, U., Subhan, F., Shahid, M. M., Akbar, S., Ahmad, N., Ali, G., Fawad, K., & Sewell, R. D. E. (2016) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-016-1048-6 · Cited by 68
Lind, A., Khoonsari, P. E., Sjödin, M. O. D., Katila, L., Wetterhall, M., Gordh, T., & Kultima, K. (2016) · Neuromodulation Technology at the Neural Interface · doi:10.1111/ner.12473 · Cited by 72
Malcangio, M. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.05.012 · Cited by 71
“In the case of systemic diazepam, the site of action appears to be the spinal cord where GABAA receptor subunits α2 and α3 are responsible for analgesic effects (Knabl et al., 2008; Knabl et al., 2009).”
Jiang, J., Shen, Y. Y., Li, J., Lin, Y., Luo, C. X., & Zhu, D. Y. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.03.056 · Cited by 69
Cheng, T., Wallace, D. M., Ponteri, B. B., & Tuli, M. (2018) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s164307 · Cited by 66
“L-838,417 has seen popular use in research and is a partial agonist of α 2 , α 3 , and α 5 containing GABA A receptors.(22) Other compounds with low or absent α 1 subtype efficacy such as imidazenil, TPA123, and TPA023, are also shown to be sedation-free anxiolytics, revealing the importance of the α 1 subtype in the…”
Progress in automating patch clamp cellular physiology
Annecchino, L. A., & Schultz, S. R. (2018) · Brain and Neuroscience Advances · doi:10.1177/2398212818776561 · Cited by 73
“…(Vasilyev et al., 2009), Cav3 calcium channels (Swensen et al., 2012; Xie et al., 2007; Zamponi, 2016), and GABAA and GABAB receptors (Enna and McCarson, 2006; Ji and Neugebauer, 2011; Kahle et al., 2016; Knabl et al., 2008) (see also Bagal et al. (2014) and Chambard et al. (2014) for reviews).”
BackgroundHistone acetylation and histone deacetylation in neuropathic pain: An unresolved puzzle?
Khangura, R. K., Bali, A., Jaggi, A. S., & Singh, N. (2016) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2016.12.001 · Cited by 69
Spinal dis-inhibition in inflammatory pain
Zeilhofer, H. U., & Zeilhofer, U. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.056 · Cited by 65
Self-citationJensen, H. S., Nichol, K. E., Lee, D., & Ebert, B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0088456 · Cited by 72
Atack, Jr., Hallett, D., Tye, S., Wafford, K., Ryan, C., Sanabria-Bohórquez, S., Eng, W.-S., Gibson, R., Burns, H., Dawson, G., et al. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881109354928 · Cited by 63
“…anxiolytic efficacy; de Haas et al., 2007) should encourage the pursuit of such novel compounds not only as potential non-sedating anxiolytics (Mirza et al., 2008) but also for other indications such as schizophrenia (Lewis et al., 2008) and pain (Knabl et al., 2008; Munro et al., 2008, 2009).”
BackgroundGABAAReceptor Trafficking Is Regulated by Protein Kinase Cε and theN-Ethylmaleimide-Sensitive Factor
Chou, W.-H., Wang, D., McMahon, T., Qi, Z.-H., Song, M., Zhang, C., Shokat, K. M., & Messing, R. O. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.0270-10.2010 · Cited by 67
“…GABAA receptor signaling contributes to several neuropsychiatric conditions including epilepsy (Goodkin et al., 2008), schizophrenia (Charych et al., 2009), anxiety and depression (Kalueff and Nutt, 2007; Charych et al., 2009), substance abuse (Kumar et al., 2004), and pain (Knabl et al., 2008).”
BackgroundVolz, M. S., Farmer, A., & Siegmund, B. (2015) · Pain · doi:10.1097/j.pain.0000000000000386 · Cited by 67
“”(24,63) Pain-associated brain areas process sensory input and generate the perception of pain and adjunct emotions.(9,30,63) Pain-related central networks are altered through an increase of synaptic connections and the stabilization of (preexisting) synaptic connections.”
BackgroundNickolls, S. A., Gurrell, R., van Amerongen, G., Kammonen, J., Cao, L., Brown, A. R., Stead, C., Mead, A. N., Watson, C. A., Hsu, C. C., et al. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14119 · Cited by 66
“…tool compounds, have assigned the sedative effects of BZDs to α1 activity (McKernan et al., 2015), anxiolytic and analgesic activity to α2/3 subunits (Dias et al., 2005; Atack et al., 2006; Knabl et al., 2008) and some of the effects on memory function to α5 receptors (Dawson et al., 2006).”
BackgroundLorenzo, L.-É., Godin, A. G., Wang, F., St-Louis, M., Carbonetto, S., Wiseman, P. W., Ribeiro-da-Silva, A., & Koninck, Y. D. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0159-14.2014 · Cited by 68
Asiedu, M. N., Mejia, G. L., Hübner, C. A., Kaila, K., & Price, T. J. (2014) · Journal of Pain · doi:10.1016/j.jpain.2014.01.001 · Cited by 65
“There is strong evidence that spinal benzodiazepines are effective analgesics at appropriate doses in animals [2; 3; 14; 19; 27] and in humans [42; 44; 48].”
BackgroundMethodInfluentialImpairment of GABAB receptor dimer by endogenous 14‐3‐3ζ in chronic pain conditions
Laffray, S., Bouali‐Benazzouz, R., Papon, M.-A., Favereaux, A., Jiang, Y., Holm, T., Spriet, C., Desbarats, P., Fossat, P., Feuvre, Y. L., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.161 · Cited by 69
“…of inhibitory transmission (Moore et al , 2002; Bardoni et al , 2007; Ferrini et al , 2010), or loss of GABAA inhibition (Coull et al , 2005; Knabl et al , 2008), our data support the view that disinhibition dramatically twists the excitability of spinal neurons and leads to pain…”
Developing nociceptor-selective treatments for acute and chronic pain
Jayakar, S. S., Shim, J., Jo, S., Bean, B. P., Singeç, I., & Woolf, C. J. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abj9837 · Cited by 63
Synaptic Inhibition and Disinhibition in the Spinal Dorsal Horn
Prescott, S. A. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2014.11.008 · Cited by 79
Metadata
- Authors
- Knabl, J., Witschi, R., Hösl, K., Reinold, H., Zeilhofer, U. B., Ahmadi, S., Brockhaus, J., Sergejeva, M., Hess, A., Brune, K., Fritschy, J.-M., Rudolph, U., Möhler, H., & Zeilhofer, H. U.
- Affiliations
- Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
- University of Zurich (CH)
- University of Bonn (DE)
- Harvard University (US)
- Corresponding author
- Zeilhofer, Hanns Ulrich
- Venue
- Nature
- Published
- 2008-01
- Volume
- 451
- Issue
- 7176
- Pages
- 330-334
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2011606970
- Cited by
- 438
- References
- 43
- Citations by year
- 2026: 10 · 2025: 12 · 2024: 13 · 2023: 10 · 2022: 15 · 2021: 22 · 2020: 24 · 2019: 17 · 2018: 23 · 2017: 21 · 2016: 27 · 2015: 33 · 2014: 27 · 2013: 38 · 2012: 38
- FWCI
- 23.97
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Health Sciences › Medicine › Anesthesiology and Pain Medicine › Pain Management and Treatment
- Keywords
- chronic pain, neuropathic pain, inflammatory pain, GABAA receptor subtypes, alpha2 subunit, alpha3 subunit, synaptic inhibition, dorsal horn, GABAergic neurotransmission, knock-in mice, analgesia, sedation, tolerance (pharmacology and immunology), pain-related brain activity
- MeSH terms
- Analgesics, Animals, Brain, Capsaicin, Chronic Disease, Diazepam, Disease Models, Animal, Fluorobenzenes, Formaldehyde, Ganglia, Spinal, Hot Temperature, Inflammation, Male, Neurons, Organ Specificity, Pain, Receptors, GABA-A, Spinal Cord, Triazoles, Rats, Wistar, Protein Isoforms, Protein Subunits, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.